期刊文献+

A20基因甲基化对弥漫性大B细胞性淋巴瘤的影响 被引量:4

Effects of the methylation of A20 gene on diffuse large B cell lymphoma
下载PDF
导出
摘要 目的检测弥漫性大B细胞性淋巴瘤(DLBCL)中A20基因甲基化状况,探讨其对DLBCL临床过程及预后的影响。方法通过组织学观察及免疫表型检测筛选104例DLBCL,收集其临床病理资料及随访;并以甲基化特异性PCR(MSP)法检测A20基因启动子区5'Cp G岛甲基化的情况;以免疫组化SP法检测肿瘤细胞P糖蛋白(Pg P)和Ki-67蛋白的表达。结果 104例DLBCL中,A20基因甲基化率为26%(27/104),活化后B细胞样(ABC)-DLBCL组甲基化率(35.4%)高于生发中心B细胞样(GCB)DLBCL组(10.2%)(P<0.05);Pg P阳性率65.4%(68/104),A20基因甲基化组Pg P阳性率(85.2%)明显高于无甲基化组(58.4%)(P<0.05);A20基因甲基化与非甲基化组之间Ki-67高表达病例与低表达病例均无明显差异(P>0.05);A20基因甲基化病例的复发率明显高于无甲基化病例(P<0.05);生存分析发现,两组病例的生存状况差异不显著。结论 DLBCL部分病例存在A20基因甲基化,以ABC-DBLCL病例多见。A20基因甲基化与DLBCL的复发有关,且可能通过NF-κB异常活化而促进肿瘤细胞Pg P蛋白表达,从而影响DLBCL的化疗效果。 Objective To detect the methylation of A20 gene,and to investigate the relationship between the methylation of A20 gene and clinicopathological features,prognosis in the DLBCL.Methods 104 cases with DLBCL were selected by reviewing of morphology and examining immunohistochemical phenotype.The methylation of A20 gene was detected by methylation-specific PCR( MSP).The expression of Pg P and Ki-67 was detected by immunohistochemical stain( IHC).Collection of clinicopathological data,follow-up and statistical analysis were done.Results The methylation of A20 gene was identified in 27 of 104 patiens( 26%,27 /104,).It was more frequent in ABC-DLBCL( 23 /65,35.4%) than GCBDLBCL( 4 /39,10.2%,P = 0.003);The positive expression for Pg P was 65.3%( 68 /104).The stastistical difference in positive expression for Pg P was found between the cases with methylation( 23) and non-methylation( 45) of A20 gene( P =0.012);Both the cases of high and low expression for Ki67 were no statistical significance between the cases with methylation and non-methylation( P = 0.607).Relapse was more common in the patient with methylation of A20( 14 /18)gene than those with non-methylation( 20 /44,P = 0.017);There was no difference in survival between two groups.Conclusion The methylation of A20 gene exists in some patients with DLBCL,especially in those with ABC-DLBCL.It associates with the relapse of the lymphoma.It also may associate with drug-resistant of DLBCL by indirectly promoting the expression of Pg P,through a way decreasing negative regulation of NF-ΚB.
出处 《诊断病理学杂志》 CSCD 2015年第12期772-776,共5页 Chinese Journal of Diagnostic Pathology
基金 国家自然科学基金(A20基因11-13)(81160299)
关键词 淋巴瘤 A20基因 DNA甲基化 预后 Lymphoma A20 gene DNA methylation Prognosis
  • 相关文献

参考文献12

  • 1Ferch U,Kloo B,Gewies A,et al.Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells[J].J Exp Med,2009,206(11):2313-2320.
  • 2Li Q,Verma IM.NF-κB regulation in the immune system[J].Nat Rev Immunol,2002,2(10):725-734.
  • 3Malynn BA,Ma A.A20 takes on tumors:tumor suppression by an ubiquitin-editing enzyme[J].J Exp Med,2009,206(5):977-980.
  • 4Compagno M,Lim WK,Grunn A.Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma[J].Nature,2009,459(7247):717-721.
  • 5Düwel M,Welteke V,Oeckinghaus A.A20 negatively regulates T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains[J].J Immunol,2009,182(12):7718-7728.
  • 6王漪,刘心,张海涛,余敏,王晖.白血病细胞中NF-κB调控MDR1基因、P糖蛋白及逆转耐药的研究[J].中国实验血液学杂志,2007,15(5):950-954. 被引量:12
  • 7Jaffe ES,Harris NL,Stein H,et al.World Health Organization classification of tumours.Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M].Thrid Edition.Lyon:IARC Press,2003.122-135.
  • 8Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J].Blood,2004,103(1):275-282.
  • 9Castellucci P,Nanni C,Farsad M,et al.Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma:prevalence and scan interpretation[J].Nucl Med Commun,2005,26(8):689-694.
  • 10陈琴,杨文秀,李品浩.弥漫性大B细胞性淋巴瘤中CARMA1基因突变的检测及意义[J].诊断病理学杂志,2014,21(9):576-578. 被引量:1

二级参考文献24

  • 1Ogretmen B, Safa AR. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region. Biochemistry, 1999; 38:2189-2199
  • 2Ros JE, Schuetz JD, Geuken M, et al. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling. Hepatology, 2001; 33: 1425-1431
  • 3Um JH, Kang CD, Lee BG, et al. Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance. Oncogene, 2001; 20:6048-6056
  • 4Kuo MT, Liu Z, Wei Y, et al. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappa B signaling. Oncogene, 2002; 21:1945-1954
  • 5Meyer M, Schreck R, Baeuerde PA. H2O2 and antioxidants have opposite effects on activation of NF-kappaB and AP-1 in intact cells: AP-1 as secondary antioxidant responsive factor. EMBO J, 1993; 12: 2005-2015
  • 6Lauzurica P, MartinezMartinez S, Marazuela M, et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol, 1999; 29: 1890-1900
  • 7Bentires-Alj M, Barbu V, Fillet M, et al. NF-kappa B transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 2003; 22: 90-97
  • 8Flens MJ, Zaman GJ, Vander-Valk P, et al. Tissue distribution of the multidrug resistance protein. Am J Pathol, 1996; 148: 1237-1247
  • 9Higgins CF. The multidrug resistance P-glycoprotein. Curr Opin Cell Biol, 1993; 5: 684-687
  • 10Grant CE, Valdimarsson G, Hipfner DR, et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res, 1994; 54: 357-361

共引文献64

同被引文献9

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部